Sentences with phrase «deaths in diabetes patients»

That's particularly significant since people with diabetes have a significantly higher risk of developing cardiovascular conditions — and Lilly's drug was shown to cut the cardiovascular - related deaths in diabetes patients by a staggering 38 % in clinical trials.

Not exact matches

The associations between age (or age at diagnosis), diabetes duration and major macrovascular events, all - cause death and major microvascular events were examined in 11,140 patients with type 2 diabetes randomly allocated to intensive or standard glucose control in this study.

The results also indicate that older patients in any age group had higher incidence of all outcomes (nonfatal complications and death) if they had diabetes for a longer, compared with shorter, duration of time.

In patients who are obese or have type II diabetes, fat often accumulates in the liver, sometimes leading to organ malfunction and even deatIn patients who are obese or have type II diabetes, fat often accumulates in the liver, sometimes leading to organ malfunction and even deatin the liver, sometimes leading to organ malfunction and even death.

The second question is more difficult to answer than it might seem because the low prevalence of cancer and diabetes in Laron patients is counterbalanced by an abnormally high risk of death from other causes, especially accidents, alcohol, and convulsive disorders.

The blood pressure medication angiotensin - converting enzyme inhibitors (ACEIs) appear to reduce major cardiovascular events and death, as well death from all other causes, in patients with diabetes, while angiotensin II receptor blockers (ARBs) appear to have no such effect on those outcomes.

Post-transplant, patients with diabetes experienced a significant decline in major fatal / nonfatal cardiac events and deaths from infections over time.

Influenza remains a major health problem in the United States, resulting each year in an estimated 36,000 deaths and 200,000 hospitalizations.4 Those who have been shown to be at high risk for the complications of influenza infection are children 6 to 23 months of age; healthy persons 65 years of age or older; adults and children with chronic diseases, including asthma, heart and lung disease, and diabetes; residents of nursing homes and other long - term care facilities; and pregnant women.4 It is for this reason that the Centers for Disease Control and Prevention (CDC) has recommended that these groups, together with health care workers and others with direct patient - care responsibilities, should be given priority for influenza vaccination this season in the face of the current shortage.1 Other high - priority groups include children and teenagers 6 months to 18 years of age whose underlying medical condition requires the daily use of aspirin and household members and out - of - home caregivers of infants less than 6 months old.1 Hence, in the case of vaccine shortages resulting either from the unanticipated loss of expected supplies or from the emergence of greater - than - expected global influenza activity — such as pandemic influenza, which would prompt a greater demand for vaccination5 — the capability of extending existing vaccine supplies by using alternative routes of vaccination that would require smaller doses could have important public health implications.

In some patients with coronary artery disease, mental stress may precipitate ischemia — a deficiency in blood flow to the heart â $ «a risk factor for adverse events and death independent of other cardiovascular risk factors such as smoking, cholesterol and diabeteIn some patients with coronary artery disease, mental stress may precipitate ischemia — a deficiency in blood flow to the heart â $ «a risk factor for adverse events and death independent of other cardiovascular risk factors such as smoking, cholesterol and diabetein blood flow to the heart â $ «a risk factor for adverse events and death independent of other cardiovascular risk factors such as smoking, cholesterol and diabetes.

In the Jupiter trial, a greater percentage of participants taking Crestor developed diabetes during the study; there were also 13 deaths related to gastrointestinal disorders and 18 patients who reported «a confusional state.»

JAMA even recently published an article discussing its utility in weight loss and type 2 diabetes, both closely related to several common cancers like breast and prostate cancer.9 This effect, in itself, may improve cancer outcomes since weight gain is associated with an increased risk of recurrence and death, thus the mediccal should seriously consider the ketogenic diet, periodic ketosis, or simply low - carb to help patients achieve and maintain a healthy weight and healthy metabolic status.10 After years of taking continuous shots for their views, the modern day pioneers like Jeff Volek are finally receiving some vindication.

A long - term study of Tekturna and patients with impaired kidneys and type 2 diabetes showed that the risks of kidney impairment, raised potassium levels, low blood pressure, stroke, and death went up in patients that took the medication.

Such drugs as Zyprexa, which was meant to treat depression or bipolar disorder was found to be causing diabetes in many patients and also led to serious side effects such as pancreatitis, tumors and even death.